http://www.us-gsk.com/html/media-news/ GlaxoSmithKline is a leading healthcare company that helps people to do more, feel better and live longer. This RSS feed contains press releases and investor news. http://us.gsk.com/html/media-news/pressreleases/2010/2010_pressrelease_10022.htm GlaxoSmithKline CEO Andrew Witty today dedicated a new production facility at its Nashik site in India to the manufacture of albendazole, part of a combination treatment used within the World Health Organization’s (WHO) Global Programme to Eliminate Lymphatic Filariasis (LF). Mon, 8 Mar 2010 10:30:00 GMT http://us.gsk.com/html/media-news/pressreleases/2010/2010_pressrelease_10022.htm http://us.gsk.com/html/media-news/pressreleases/2010/2010_us_pressrelease_10020.htm Today, GlaxoSmithKline (GSK) responded to the recently released Senate Committee on Finance’s January 2010 “Staff Report on GlaxoSmithKline and the Diabetes Drug Avandia” (the “Staff Report”) by releasing a White Paper. Wed, 24 Feb 2010 14:30:00 GMT http://us.gsk.com/html/media-news/pressreleases/2010/2010_us_pressrelease_10020.htm http://us.gsk.com/html/media-news/pressreleases/2010/2010_pressrelease_10017.htm Because the safety and health of our consumers is our primary concern, GlaxoSmithKline (GSK) Consumer Healthcare is issuing a Consumer Advisory warning consumers about the potential health risks associated with long-term excessive use of zinc-containing denture adhesives. Thurs, 18 Feb 2010 17:00:00 GMT http://us.gsk.com/html/media-news/pressreleases/2010/2010_pressrelease_10017.htm http://us.gsk.com/html/media-news/pressreleases/2010/2010_us_pressrelease_10013.htm GlaxoSmithKline and XenoPort, Inc. Wednesday received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for Horizant™(gabapentin enacarbil) Extended-Release Tablets, an investigational non-dopaminergic treatment for moderate-to-severe primary Restless Legs Syndrome (RLS). Wed, 17 Feb 2010 02:15:00 GMT http://us.gsk.com/html/media-news/pressreleases/2010/2010_us_pressrelease_10013.htm http://us.gsk.com/html/media-news/pressreleases/2010/2010_us_pressrelease_10012.htm Nonprofits Providing Access to Healthcare to Receive Up to $400,000 in Awards – Application Deadline March 29, 2010 Mon, 15 Feb 2010 17:00:00 GMT http://us.gsk.com/html/media-news/pressreleases/2010/2010_us_pressrelease_10012.htm http://gsk-us.com/html/media-news/pressreleases/2010/2010_us_pressrelease_10011.htm GlaxoSmithKline today announced the launch of CARES by GSK, a comprehensive program that provides a single point of contact to GSK services and programs designed to improve access to GSK oncology and specialty medications Wed, 10 Feb 2010 09:00:00 GMT http://gsk-us.com/html/media-news/pressreleases/2010/2010_us_pressrelease_10011.htm http://us.gsk.com/html/media-news/pressreleases/2010/2010_pressrelease_10014.htm FGSK today announces the formation of a new standalone unit specialising in the development and commercialisation of medicines for rare diseases. Thurs, 4 Feb 2010 14:00:00 GMT http://us.gsk.com/html/media-news/pressreleases/2010/2010_pressrelease_10014.htm http://us.gsk.com/html/media-news/pressreleases/2010/2010_pressrelease_10015.htm GSK today announces the appointment of Philippe Fauchet as President of GSK Japan Thurs, 4 Feb 2010 14:00:00 GMT http://us.gsk.com/html/media-news/pressreleases/2010/2010_pressrelease_10015.htm http://www.gsk.com/investors/quarterly_results.htm GSK announces Q4 2009 results Thu, 04 Feb 2010 12:00:00 GMT http://www.gsk.com/investors/quarterly_results.htm http://us.gsk.com/html/media-news/pressreleases/2010/2010_us_pressrelease_10010.htm TUMS® and “Dr. Gourmet” Offer a New Spin on Game Day Eating to Help You Stay Healthy and Avoid Heartburn Tue, 2 Feb 2010 20:00:00 GMT http://us.gsk.com/html/media-news/pressreleases/2010/2010_us_pressrelease_10010.htm